As new PrEP products move out of clinical trials and toward market entry, implementation research has a pivotal role to play in guiding the introduction and scale-up of these new products in real-world service delivery settings.
In this webinar, we will hear from the investigators of new implementation studies offering choice of PrEP products, including oral PrEP, injectable cabotegravir, and the dapivirine vaginal ring. Presenters will discuss their study designs and PrEP choice interventions, and webinar attendees will learn how these groundbreaking studies spanning diverse geographies and priority populations will generate critical evidence and lessons for HIV prevention efforts across the globe.
Watch the recording here.
*All recordings and webinar resources are available on PrEPWatch at Global PrEP Learning Network – PrEPWatch.